Mitsubishi Chemical Holdings Corporation is a holding company established through the merger of Mitsubishi Chemical and Mitsubishi Pharma.  The Company manages operation of its subsidiaries.

Notice Regarding Formulation Of “Kaiteki Vision 35” And “New Medium-Term Management Plan 2029”

Operational Summary For The First Half Of The Fiscal Year Ending March 31, 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mitsubishi Chemical (4188 JP)

Notice Regarding Formulation Of “Kaiteki Vision 35” And “New Medium-Term Management Plan 2029”

Operational Summary For The First Half Of The Fiscal Year Ending March 31, 2025

Notice On Differences Between Financial Results Forecast & Financial Results For The 1h Of Fy2024, Ending Mar 31, 2025, & Revisions To Annual Forecast

Consolidated Financial Results For The First Half Of The Fiscal Year Ending March 31, 2025 (Under Ifrs)

Notice Concerning Change Of Specified Subsidiary (Share Transfer)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)